SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

Akari Therapeutics Plc - ADR

Akari Therapeutics

Akari Therapeutics is capturing significant market attention following positive preclinical data for its ADC candidate AKTX-101 in treating KRAS-mutated pancreatic cancer. The community is actively debating the stock's potential for a parabolic run, with many investors focusing on the company's micro-float status and comparing recent moves to previous high-volatility momentum plays.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp (BULL) is seeing heightened volatility and intense social media discussion as traders speculate on potential earnings leaks and manipulation ahead of the company's latest quarterly report. The community remains deeply divided, with bulls pointing toward the firm's growth in customer assets and upcoming regulatory changes as long-term catalysts, while bears focus on rising operating expenses and persistent downward pressure on the share price.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is trending after reporting strong quarterly results that surpassed earnings and revenue expectations, helping to alleviate concerns regarding the durability of enterprise software demand. The community is actively discussing the company's progress in AI integration and whether these results signal a stabilization for the broader software sector against the rising narrative of AI-driven disruption.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom Video Communications, Inc.

Zoom is trending after reporting a quarterly earnings beat and raising its full-year guidance, bolstered by strong enterprise demand and a new $1 billion share buyback authorization. Community sentiment remains split, with bulls pointing to the company's robust cash position and strategic AI investments as a value opportunity, while bears remain skeptical of long-term growth prospects due to intense competition and stagnant price action.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor Corp. is capturing significant market attention as investors weigh the company's strong brand performance from HOKA and UGG against concerns over supply chain headwinds and institutional downgrades. While community sentiment remains divided between bulls focused on solid revenue growth and buyback initiatives and bears concerned about weakening leadership and sector-wide competitive pressure, market participants are bracing for upcoming earnings to provide clarity on the stock's future trajectory.

UP Fintech Holding Ltd. is an online brokerage firm that focuses on global investors. It provides an online trading platform that enables investors to trade in equities and other financial instruments on multiple exchanges around the world. The firm offers products and services, as well as a user experience to customers through its mobile first strategy. The company was founded by Tian Hua Wu in June 2014 and is headquartered in Singapore.

UP Fintech Holding Ltd - ADR

UP Fintech is facing significant volatility as investors react to potential regulatory penalties in China, fueling concerns about the stability of the company's overseas brokerage operations. While some traders view the resulting pullback as a buying opportunity given the company's strong revenue growth and client account expansion, others are bracing for further downside amid broader skepticism toward Chinese ADRs.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is generating significant market buzz as the company launches its R2 configurator and prepares for upcoming customer deliveries, drawing strong interest from investors and the broader EV community. While social media sentiment remains divided between hopeful bulls focused on production ramps and strategic partnerships and skeptical bears concerned about stock performance and capital burn, the stock remains a high-engagement topic as stakeholders wait for concrete delivery and order data to potentially spark a technical reversal.

Futu Holdings Ltd. engages in the provision of digitalized financial services. It offers securities brokerage and wealth management products. The company was founded by Leaf Hua Li in December 2007 and is headquartered in Hong Kong.

Futu Holdings Ltd - ADR

Futu Holdings is trending as shares face heavy downward pressure following reports of a two-year regulatory crackdown in China targeting overseas trading platforms. The community is actively debating whether to buy the dip as a value play or avoid the stock entirely due to persistent geopolitical risks and regulatory uncertainty.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is surging as the success of a competitor's late-stage trial for a similar breast cancer drug class validates the potential of its own pipeline and fuels intense speculation about a future buyout. Community members are actively debating the sustainability of the rally versus risks like dilution, while institutional ownership and the potential for a short squeeze remain key focal points.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is seeing a surge in investor attention as the community identifies a classic short squeeze setup, fueled by high short interest, a shrinking float due to aggressive share buybacks, and anticipation ahead of earnings. Traders are actively discussing the stock's potential for parabolic movement, drawing comparisons to other high-profile squeeze plays while monitoring key technical resistance levels for a potential breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ISRG's SP Platform: Early-Stage Growth or Next TAM Expansion Driver?

ISRG's SP platform sees Q1 2026 procedures jump 68%, with new approvals and tools raising a key question: TAM expansion or procedure shift?

Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum

ABT's EPD unit posts 9% Q1 sales growth as biosimilars and emerging market demand support its long-term expansion plans.

Silver Economy Investing: Why the Healthcare Giants Are in Focus

Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.

Boston Scientific Bets on Growth Through Strategic M&A Deals 

BSX expands into fast-growing medtech segments with acquisitions spanning urology, pain management and vascular devices.

ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now?

Abbott vs. Zimmer Biomet: surgical equipment stocks face diverging growth, acquisitions, and valuation shifts as investors weigh momentum and margins. 

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know  

Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

How Abbott's Volume-Driven Nutrition Strategy Is Shaping Up

ABT shifts to a volume-led Nutrition strategy with pricing moves and new product launches after Q1 sales declined 6%.

Jim Cramer Compares the Current Selloff in Abbott Labs to the 1999 Market Environment

Jim Cramer Compares the Current Selloff in Abbott Labs to the 1999 Market Environment...

Should You Buy, Hold or Sell BSX Stock Amid Cardiovascular Boom?

Boston Scientific rides on cardiovascular device growth with FARAPULSE and WATCHMAN momentum, but margin pressure and weaker estimates cloud the outlook.

Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold?   

ABT's Q1 beat was overshadowed by Exact Sciences dilution, legal risks and weak Diagnostics trends as shares hit a 52-week low.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Current Price	$87.77
Prev Close	$88.38
Open	$88.60
Dividend Yield	1.92%
50-Day Moving Average	$96.48
Beta	0.25
Avg. Volume	12.46M
PE Ratio	24.45

52-Week High	$139.06
52-Week Low	$81.97
Market Capitalization	$153.94B
EPS (Annual)	$3.72
Price to Book	2.94
Revenue Per Employee	$385,460.87

ABT
Abbott Laboratories

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest ABT News

ABTAbbott Laboratories